Literature DB >> 17317153

BRCA1 promoter deletions in young women with breast cancer and a strong family history: a population-based study.

L D Smith1, A A Tesoriero, S J Ramus, G Dite, S G Royce, G G Giles, M R E McCredie, J L Hopper, M C Southey.   

Abstract

Women diagnosed with breast cancer before the age of 40 years who have a strong family history of breast and/or ovarian cancer were selected from an Australian population-based case-control-family study for large deletion screening within the BRCA1 promoter. Deletions within the BRCA1 promoter region are usually not detected by the methods applied in routine clinical mutation detection strategies. Fifty-one of the 66 women (77%) who met our inclusion criteria were tested for promoter deletions using linkage disequilibrium analysis of two BRCA1 polymorphic sites (C/G1802 and Pro871Leu) and multiplex ligation-dependent probe amplification. Two cases of BRCA1 promoter deletion involving exons 1A-2 and exons 1A-23 were detected. The morphology of the breast cancers arising in these women with BRCA1 promoter deletions was consistent with the morphology associated with other germline BRCA1 mutations. Large genomic deletions that involve the promoter regions of BRCA1 make up 20% (2/10) of all known BRCA1 mutations in this group of young women with a strong family history of breast and ovarian cancer. Our data support the inclusion of testing for large genomic alterations in the BRCA1 promoter region in routine clinical mutation detection within BRCA1.

Entities:  

Mesh:

Year:  2007        PMID: 17317153      PMCID: PMC2222980          DOI: 10.1016/j.ejca.2007.01.011

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

1.  Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method.

Authors:  Frans B L Hogervorst; Petra M Nederlof; Johan J P Gille; Cathal J McElgunn; Maartje Grippeling; Roelof Pruntel; Rein Regnerus; Tibor van Welsem; Resie van Spaendonk; Fred H Menko; Irma Kluijt; Charlotte Dommering; Senno Verhoef; Jan P Schouten; Laura J van't Veer; Gerard Pals
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

2.  Breast cancer in Australian women under the age of 40.

Authors:  M R McCredie; G S Dite; G G Giles; J L Hopper
Journal:  Cancer Causes Control       Date:  1998-03       Impact factor: 2.506

3.  Regulation of BRCA1.

Authors:  M A Brown; H Nicolai; C F Xu; B L Griffiths; K A Jones; E Solomon; L Hosking; J Trowsdale; D M Black; R McFarlane
Journal:  Nature       Date:  1994 Dec 22-29       Impact factor: 49.962

4.  Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.

Authors:  J L Hopper; M C Southey; G S Dite; D J Jolley; G G Giles; M R McCredie; D F Easton; D J Venter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-09       Impact factor: 4.254

5.  Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS).

Authors:  J L Hopper; G Chenevix-Trench; D J Jolley; G S Dite; M A Jenkins; D J Venter; M R McCredie; G G Giles
Journal:  J Natl Cancer Inst Monogr       Date:  1999

6.  Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family.

Authors:  J Swensen; M Hoffman; M H Skolnick; S L Neuhausen
Journal:  Hum Mol Genet       Date:  1997-09       Impact factor: 6.150

7.  BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.

Authors:  A Petrij-Bosch; T Peelen; M van Vliet; R van Eijk; R Olmer; M Drüsedau; F B Hogervorst; S Hageman; P J Arts; M J Ligtenberg; H Meijers-Heijboer; J G Klijn; H F Vasen; C J Cornelisse; L J van 't Veer; E Bakker; G J van Ommen; P Devilee
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

8.  Dominant negative ATM mutations in breast cancer families.

Authors:  Georgia Chenevix-Trench; Amanda B Spurdle; Magtouf Gatei; Helena Kelly; Anna Marsh; Xiaoqing Chen; Karen Donn; Margaret Cummings; Dale Nyholt; Mark A Jenkins; Clare Scott; Gulietta M Pupo; Thilo Dörk; Regina Bendix; Judy Kirk; Katherine Tucker; Margaret R E McCredie; John L Hopper; Joseph Sambrook; Graham J Mann; Kum Kum Khanna
Journal:  J Natl Cancer Inst       Date:  2002-02-06       Impact factor: 13.506

9.  Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.

Authors:  Gillian S Dite; Mark A Jenkins; Melissa C Southey; Jane S Hocking; Graham G Giles; Margaret R E McCredie; Deon J Venter; John L Hopper
Journal:  J Natl Cancer Inst       Date:  2003-03-19       Impact factor: 13.506

10.  Germline BRCA1 promoter deletions in UK and Australian familial breast cancer patients: Identification of a novel deletion consistent with BRCA1:psiBRCA1 recombination.

Authors:  Melissa A Brown; Li-Jan Lo; Aurélie Catteau; Chun-Fang Xu; Geoffrey J Lindeman; Shirley Hodgson; Ellen Solomon
Journal:  Hum Mutat       Date:  2002-04       Impact factor: 4.878

View more
  11 in total

1.  Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study.

Authors:  Judy Mouchawar; Christopher Korch; Tim Byers; Todd M Pitts; Efang Li; Margaret R E McCredie; Graham G Giles; John L Hopper; Melissa C Southey
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

2.  Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer.

Authors:  Ee Ming Wong; Melissa C Southey; Stephen B Fox; Melissa A Brown; James G Dowty; Mark A Jenkins; Graham G Giles; John L Hopper; Alexander Dobrovic
Journal:  Cancer Prev Res (Phila)       Date:  2010-10-26

3.  Genome-wide DNA methylation assessment of 'BRCA1-like' early-onset breast cancer: Data from the Australian Breast Cancer Family Registry.

Authors:  Cameron M Scott; Ee Ming Wong; JiHoon Eric Joo; Pierre-Antoine Dugué; Chol-Hee Jung; Neil O'Callaghan; James Dowty; Graham G Giles; John L Hopper; Melissa C Southey
Journal:  Exp Mol Pathol       Date:  2018-11-10       Impact factor: 3.362

4.  BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research.

Authors:  Susan L Neuhausen; Hilmi Ozcelik; Melissa C Southey; Esther M John; Andrew K Godwin; Wendy Chung; Jeniffer Iriondo-Perez; Alexander Miron; Regina M Santella; Alice Whittemore; Irene L Andrulis; Saundra S Buys; Mary B Daly; John L Hopper; Daniela Seminara; Ruby T Senie; Mary Beth Terry
Journal:  Breast Cancer Res Treat       Date:  2008-08-14       Impact factor: 4.872

5.  Is MSH2 a breast cancer susceptibility gene?

Authors:  Ee Ming Wong; Andrea A Tesoriero; Gulietta M Pupo; Margaret R E McCredie; Graham G Giles; John L Hopper; Graham J Mann; David E Goldgar; Melissa C Southey
Journal:  Fam Cancer       Date:  2007-10-06       Impact factor: 2.375

6.  Morphological predictors of BRCA1 germline mutations in young women with breast cancer.

Authors:  M C Southey; S J Ramus; J G Dowty; L D Smith; A A Tesoriero; E E M Wong; G S Dite; M A Jenkins; G B Byrnes; I Winship; K-A Phillips; G G Giles; J L Hopper
Journal:  Br J Cancer       Date:  2011-02-22       Impact factor: 7.640

7.  A PALB2 mutation associated with high risk of breast cancer.

Authors:  Melissa C Southey; Zhi L Teo; James G Dowty; Fabrice A Odefrey; Daniel J Park; Marc Tischkowitz; Nelly Sabbaghian; Carmel Apicella; Graham B Byrnes; Ingrid Winship; Laura Baglietto; Graham G Giles; David E Goldgar; William D Foulkes; John L Hopper
Journal:  Breast Cancer Res       Date:  2010-12-23       Impact factor: 6.466

8.  Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry.

Authors:  Letitia D Smith; Andrea A Tesoriero; Ee M Wong; Susan J Ramus; Frances P O'Malley; Anna Marie Mulligan; Mary Beth Terry; Ruby T Senie; Regina M Santella; Esther M John; Irene L Andrulis; Hilmi Ozcelik; Mary B Daly; Andrew K Godwin; Saundra S Buys; Stephen Fox; David E Goldgar; Graham G Giles; John L Hopper; Melissa C Southey
Journal:  Breast Cancer Res       Date:  2011-01-31       Impact factor: 6.466

9.  Methylation of Breast Cancer Predisposition Genes in Early-Onset Breast Cancer: Australian Breast Cancer Family Registry.

Authors:  Cameron M Scott; JiHoon Eric Joo; Neil O'Callaghan; Daniel D Buchanan; Mark Clendenning; Graham G Giles; John L Hopper; Ee Ming Wong; Melissa C Southey
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

10.  Tumour morphology predicts PALB2 germline mutation status.

Authors:  Z L Teo; E Provenzano; G S Dite; D J Park; C Apicella; S D Sawyer; P A James; G Mitchell; A H Trainer; G J Lindeman; K Shackleton; L Cicciarelli; S S Buys; I L Andrulis; A M Mulligan; G Glendon; E M John; M B Terry; M Daly; F A Odefrey; T Nguyen-Dumont; G G Giles; J G Dowty; I Winship; D E Goldgar; J L Hopper; M C Southey
Journal:  Br J Cancer       Date:  2013-06-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.